REPORTS

Let’s Pullulate and Expand Your Business

Microbiome Therapeutics Market - Global Professional Analysis and Forecast to 2026

Jan 05, 2020  |  162 PAGES  |  REPORT CODE: CMM259751
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Microbiome Therapeutics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.8% during the forecast period.

This report presents the market size and development trends by detailing the Microbiome Therapeutics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Microbiome Therapeutics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Microbiome Therapeutics industry and will help you to build a panoramic view of the industrial development.

Microbiome Therapeutics Market, By Type:

  • Type 1

  • Type 2

  • Type 3

Microbiome Therapeutics Market, By Application:

  • Inflammatory Bowel Disease (IBD)

  • Orphan Drug

  • Immuno-oncology

  • Others

Some of the leading players are as follows:

  • Ritter Pharmaceuticals

  • Rebiotix

  • C3 Jian

  • PureTech

  • Metabogen

  • 4D Pharma

  • Enterome BioScience

  • Synthetic Biologics

  • Seres Therapeutics

  • Second Genome

  • Azitra

  • Metabiomics

  • MicroBiome Therapeutics LLC

  • Osel

  • AOBiome

  • OpenBiome

  • Interxon

  • Symberix

  • Assembly Biosciences

  • Synlogic

  • Symbiotix Biotherapies

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Microbiome Therapeutics Market: Technology Type Analysis

  • 4.1 Microbiome Therapeutics Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Microbiome Therapeutics Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Type 1

    • 4.3.2 Type 2

    • 4.3.3 Type 3

5 Microbiome Therapeutics Market: Product Analysis

  • 5.1 Microbiome Therapeutics Product Market Share Analysis, 2018 & 2026

  • 5.2 Microbiome Therapeutics Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Microbiome Therapeutics Market: Application Analysis

  • 6.1 Microbiome Therapeutics Application Market Share Analysis, 2018 & 2026

  • 6.2 Microbiome Therapeutics Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Inflammatory Bowel Disease (IBD)

    • 6.3.2 Orphan Drug

    • 6.3.3 Immuno-oncology

    • 6.3.4 Others

7 Microbiome Therapeutics Market: Regional Analysis

  • 7.1 Microbiome Therapeutics Regional Market Share Analysis, 2018 & 2026

  • 7.2 Microbiome Therapeutics Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Ritter Pharmaceuticals

    • 9.1.1 Ritter Pharmaceuticals Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Rebiotix

    • 9.2.1 Rebiotix Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 C3 Jian

    • 9.3.1 C3 Jian Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 PureTech

    • 9.4.1 PureTech Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Metabogen

    • 9.5.1 Metabogen Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 4D Pharma

    • 9.6.1 4D Pharma Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Enterome BioScience

    • 9.7.1 Enterome BioScience Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Synthetic Biologics

    • 9.8.1 Synthetic Biologics Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Seres Therapeutics

    • 9.9.1 Seres Therapeutics Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Second Genome

    • 9.10.1 Second Genome Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Azitra

    • 9.11.1 Azitra Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Metabiomics

    • 9.12.1 Metabiomics Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 MicroBiome Therapeutics LLC

    • 9.13.1 MicroBiome Therapeutics LLC Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Osel

    • 9.14.1 Osel Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 AOBiome

    • 9.15.1 AOBiome Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 OpenBiome

    • 9.16.1 OpenBiome Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Interxon

    • 9.17.1 Interxon Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Symberix

    • 9.18.1 Symberix Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Assembly Biosciences

    • 9.19.1 Assembly Biosciences Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 Synlogic

    • 9.20.1 Synlogic Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

  • 9.21 Symbiotix Biotherapies

    • 9.21.1 Symbiotix Biotherapies Company overview

    • 9.21.2 Financial performance

    • 9.21.3 Product benchmarking

    • 9.21.4 Strategic initiatives

    • 9.21.5 SWOT analysis

 

The List of Tables and Figures (Totals 93 Figures and 120 Tables)

  • Figure Type 1 Microbiome Therapeutics market, 2015 - 2026 (USD Million)

  • Figure Type 2 Microbiome Therapeutics market, 2015 - 2026 (USD Million)

  • Figure Type 3 Microbiome Therapeutics market, 2015 - 2026 (USD Million)

  • Figure Inflammatory Bowel Disease (IBD) market, 2015 - 2026 (USD Million)

  • Figure Orphan Drug market, 2015 - 2026 (USD Million)

  • Figure Immuno-oncology market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Microbiome Therapeutics market, by country, 2015 - 2026 (USD Million)

  • Table North America Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table North America Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table North America Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table Canada Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table Canada Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Europe Microbiome Therapeutics market, by country, 2015 - 2026 (USD Million)

  • Table Europe Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table Europe Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table Europe Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table Germany Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table Germany Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table France Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table France Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table Italy Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table Italy Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table Spain Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table Spain Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Microbiome Therapeutics market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table China Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table China Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table Japan Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table Japan Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table India Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table India Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Microbiome Therapeutics market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table MEA Microbiome Therapeutics market, by country, 2015 - 2026 (USD Million)

  • Table MEA Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table MEA Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table MEA Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Microbiome Therapeutics market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Microbiome Therapeutics market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Microbiome Therapeutics market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Ritter Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Rebiotix Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table C3 Jian Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table PureTech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Metabogen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table 4D Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Enterome BioScience Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Synthetic Biologics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Seres Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Second Genome Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Azitra Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Metabiomics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table MicroBiome Therapeutics LLC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Osel Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AOBiome Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table OpenBiome Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Interxon Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Symberix Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Assembly Biosciences Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Synlogic Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Symbiotix Biotherapies Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top